WASHINGTON – The Biden administration targeted 10 prescription drugs Tuesday as part of the first-ever Medicare price negotiation, a move that it said could benefit 9 million beneficiaries – including 165,000 in Arizona.
The medications, which are used to treat heart failure, blood clots, diabetes, arthritis, Crohn’s disease and more, account for the highest spending for drugs in Medicare Part D, and cost Medicare enrollees an estimated $3.4 billion in out-of-pocket expenses last year.
The…
